Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
PICASSO III: A Phase III, Placebo-Controlled Study of Doxorubicin With or Without Palifosfamide in Patients With Metastatic Soft Tissue Sarcoma.
J Clin Oncol. 2016 Nov 10;34(32):3898-3905. doi: 10.1200/JCO.2016.67.6684. Epub 2016 Sep 30.
J Clin Oncol. 2016.
PMID: 27621408
Clinical Trial.
Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial.
Chiocca EA, Yu JS, Lukas RV, Solomon IH, Ligon KL, Nakashima H, Triggs DA, Reardon DA, Wen P, Stopa BM, Naik A, Rudnick J, Hu JL, Kumthekar P, Yamini B, Buck JY, Demars N, Barrett JA, Gelb AB, Zhou J, Lebel F, Cooper LJN.
Chiocca EA, et al. Among authors: buck jy.
Sci Transl Med. 2019 Aug 14;11(505):eaaw5680. doi: 10.1126/scitranslmed.aaw5680.
Sci Transl Med. 2019.
PMID: 31413142
Free PMC article.
Clinical Trial.
Item in Clipboard
Combined immunotherapy with controlled interleukin-12 gene therapy and immune checkpoint blockade in recurrent glioblastoma: An open-label, multi-institutional phase I trial.
Chiocca EA, Gelb AB, Chen CC, Rao G, Reardon DA, Wen PY, Bi WL, Peruzzi P, Amidei C, Triggs D, Seften L, Park G, Grant J, Truman K, Buck JY, Hadar N, Demars N, Miao J, Estupinan T, Loewy J, Chadha K, Tringali J, Cooper L, Lukas RV.
Chiocca EA, et al. Among authors: buck jy.
Neuro Oncol. 2022 Jun 1;24(6):951-963. doi: 10.1093/neuonc/noab271.
Neuro Oncol. 2022.
PMID: 34850166
Free PMC article.
Clinical Trial.
Item in Clipboard
Disappearance of MMR-deficient subclones after controlled IL-12 and PD-1 inhibition in a glioma patient.
McCord M, Lukas RV, Amidei C, Demars N, Gelb A, Buck J, Sachdev S, Feldman A, Tate M, Dixit K, Brat DJ, Jennings L, Horbinski C.
McCord M, et al.
Neurooncol Adv. 2021 Mar 15;3(1):vdab045. doi: 10.1093/noajnl/vdab045. eCollection 2021 Jan-Dec.
Neurooncol Adv. 2021.
PMID: 34250480
Free PMC article.
No abstract available.
Item in Clipboard
Long-term outcomes of Sleeping Beauty-generated CD19-specific CAR T-cell therapy for relapsed-refractory B-cell lymphomas.
Srour SA, Singh H, McCarty J, de Groot E, Huls H, Rondon G, Qazilbash M, Ciurea S, Bardelli G, Buck J, Alousi A, Nieto Y, Rezvani K, Marin D, Popat U, Hosing C, Shpall EJ, Wierda WG, Kantarjian H, Champlin RE, Cooper LJ, Kebriaei P.
Srour SA, et al.
Blood. 2020 Mar 12;135(11):862-865. doi: 10.1182/blood.2019002920.
Blood. 2020.
PMID: 31961918
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite